IMMUNOGL. SNAKE ANTIVENOM, Middle East, 10ml, amp.
NST
DVACIMAS1A1
Valid Article
Last Updated on:
17/05/2024, 22:00:16
Former
Code(s):
DVACZNL0050 DVACIMAS1A DVACIMAS1AME DVACIMAS1A2
19.2 - Sera, immunoglobulins and monoclonal antibodies
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J06AA03
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
IMMUNOGLOBULIN SNAKE ANTIVENOM, Middle East (NAVPC)
This product is not always available at the central supply level. Contact your HQ advisor and check the specifications if an alternative is offered.
Full Name
Polyvalent Snake Antivenom (Equine), The National Antivenom & Vaccine Production Center (NAVPC), Saudi Arabia
Therapeutic Action
Neutralisation of snake venom
Equine serum globulins
Indications
Treatment of envenomations from snakes bites found in Middle East and North Africa:
- Puff adder (Bitis arietans)
- Horned desert viper (Cerastes cerastes)
- Saw-scaled viper (Echis carinatus)
- Mid-east saw scaled viper (Echis coloratus)
- Egyptian cobra (Naja haje)
- Desert black snake (Walterinnesia aegyptia)
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
10 ml ampoule
Must be given as Iv injection or IV infusion (in .9% NaCl).
Read the manufacturer's instructions.
Precautions for Use
Appropriate medical treatment should always be readily available in case of anaphylactic reactions following the administration of the product.
Storage
- Keep refrigerated between 2ºC and 8ºC - Protect from sunlight
- Do not freeze.